Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $197.54 | 4 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $119.04 | 1 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $38.42 | 1 | $0 (2018) |
| GlaxoSmithKline, LLC. | $24.07 | 1 | $0 (2019) |
| Mallinckrodt LLC | $16.01 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $119.04 | 1 | Takeda Pharmaceuticals U.S.A., Inc. ($119.04) |
| 2019 | $24.07 | 1 | GlaxoSmithKline, LLC. ($24.07) |
| 2018 | $54.43 | 2 | Boehringer Ingelheim Pharmaceuticals, Inc. ($38.42) |
All Payment Transactions
4 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/05/2023 | Takeda Pharmaceuticals U.S.A., Inc. | LIVTENCITY (Drug) | Food and Beverage | In-kind items and services | $119.04 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: RESPIRATORY | ||||||
| 10/09/2018 | Mallinckrodt LLC | — | Food and Beverage | In-kind items and services | $16.01 | General |
| 10/08/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $38.42 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 150 | 477 | $199,767 | $42,240 |
| 2022 | 5 | 163 | 436 | $177,936 | $36,273 |
| 2021 | 10 | 243 | 581 | $172,163 | $42,674 |
| 2020 | 5 | 197 | 536 | $199,441 | $41,300 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 24 | 213 | $62,544 | $20,089 | 32.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 73 | 167 | $75,702 | $17,446 | 23.0% |
| 31628 | Biopsy of lobe of lung using an endoscope, 1 lobe | Facility | 2023 | 17 | 31 | $30,039 | $4,123 | 13.7% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 18 | 33 | $4,422 | $315.20 | 7.1% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 18 | 33 | $27,060 | $266.12 | 1.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 29 | 191 | $55,616 | $15,571 | 28.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 72 | 144 | $58,056 | $15,467 | 26.6% |
| 31628 | Biopsy of lobe of lung using an endoscope, 1 lobe | Facility | 2022 | 19 | 32 | $31,008 | $4,507 | 14.5% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2022 | 22 | 35 | $28,700 | $382.84 | 1.3% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2022 | 21 | 34 | $4,556 | $344.73 | 7.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 31 | 260 | $74,358 | $21,458 | 28.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 65 | 145 | $55,300 | $15,829 | 28.6% |
| 31628 | Biopsy of one lobe of lung using an endoscope | Facility | 2021 | 13 | 16 | $15,504 | $2,168 | 14.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 13 | 33 | $6,505 | $1,897 | 29.2% |
| 94618 | Test for exercise-induced lung stress | Facility | 2021 | 24 | 24 | $1,416 | $436.08 | 30.8% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Facility | 2021 | 35 | 35 | $1,085 | $234.50 | 21.6% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2021 | 15 | 18 | $14,760 | $218.80 | 1.5% |
| 99152 | Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 15 minutes | Facility | 2021 | 14 | 17 | $2,278 | $170.68 | 7.5% |
| 94726 | Determination of lung volumes using plethysmography | Facility | 2021 | 11 | 11 | $341.00 | $107.69 | 31.6% |
| 94729 | Measurement of lung diffusing capacity | Office | 2021 | 11 | 11 | $275.00 | $79.86 | 29.0% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 11 | 11 | $341.00 | $73.70 | 21.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 27 | 266 | $73,257 | $22,124 | 30.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 77 | 163 | $58,364 | $13,238 | 22.7% |
| 31628 | Biopsy of one lobe of lung using an endoscope | Facility | 2020 | 28 | 33 | $31,944 | $4,827 | 15.1% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2020 | 33 | 38 | $31,160 | $747.12 | 2.4% |
About Dr. Max Weder, MD
Dr. Max Weder, MD is a Pulmonary Disease healthcare provider based in Charlottesville, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/26/2008. The National Provider Identifier (NPI) number assigned to this provider is 1548410566.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Max Weder, MD has received a total of $197.54 in payments from pharmaceutical and medical device companies, with $119.04 received in 2023. These payments were reported across 4 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($197.54).
As a Medicare-enrolled provider, Weder has provided services to 753 Medicare beneficiaries, totaling 2,030 services with total Medicare billing of $162,487. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Pulmonary Disease
- Location Charlottesville, VA
- Active Since 09/26/2008
- Last Updated 08/10/2023
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1548410566
Products in Payments
- LIVTENCITY (Drug) $119.04
- OFEV (Drug) $38.42
- TRELEGY ELLIPTA (Drug) $24.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Charlottesville
Imre Noth, Md, MD
Pulmonary Disease — Payments: $411,295
Michael Boyd, M.d, M.D
Pulmonary Disease — Payments: $7,072
Dr. Allen Burks, Md, MD
Pulmonary Disease — Payments: $5,286
Dr. Catherine Bonham, M.d, M.D
Pulmonary Disease — Payments: $3,996
Andrew Mihalek, M.d, M.D
Pulmonary Disease — Payments: $249.92
Choi Mei Adams, Fnp, FNP
Pulmonary Disease — Payments: $172.74